Clinical Diagnostics Technology & Disease Research News | 360Dx
Emerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.
About Us - 360Dx
GenomeWeb Crain Communications, Inc. 685 Third Avenue New York, NY 10017 T: 212-210-0100
Diagnostic Technologies and Applications - 360Dx
News and analysis on diagnostic technologies and applications from 360Dx.
In Brief This Week: Revvity, IntelliGenome, Angle, NowDiagnostics ...
3 天之前 · P ramana, a company that develops AI-driven health technology, this week said its autonomous whole-slide imaging system will be used in Vanderbilt University Medical Center's pathology lab.Vanderbilt expects the system to advance precision medicine and improve clinical care and patient outcomes. The university also hopes it will enable new insights into disease, resulting in the development of ...
Breaking News - 360Dx
2025年1月20日 · The Amsterdam-based biotech firm said that its melt curve analysis-based test is used as a first-tier genetic screening tool to aid the diagnosis of SMA.
Top Five Articles on 360Dx Last Week: Interest in JP Morgan …
2025年1月20日 · NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) JP Morgan Healthcare Conference, Day 1: Exact Sciences, Revvity, Qiagen, Guardant Health, Waters 2) JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Labcorp, Hologic, CareDx, More 3) JP Morgan Healthcare Conference, Day 3: Quanterix, Grail, GeneDx
Number of Dx Private Financing Deals Rose 25 Percent in 2024, …
2025年1月7日 · NEW YORK – Following a barren financing market in diagnostics resulting from the COVID-19 pandemic, private financing in the space rebounded in 2024. In 2023, the largest private financing was Harbinger Health's $140 million Series B round — the only financing above $100 million that year ...
360Dx Top 30 Falls 4 Percent in December
2025年1月2日 · Editor’s Note: We will adjust the firms listed in the 360Dx Top 30 this month based on market caps at the end of 2024. Those changes will be reflected next month when we report on the stock performance in January of the companies we track. NEW YORK – The 360Dx Top 30 fell 4 percent month over ...
Disease Research & Diagnostics News - 360Dx
News and analysis on disease research and diagnostics from 360Dx.
Despite Softness in China, Danaher Q3 Revenues Grow 3 Percent
2024年10月22日 · Note: This story has been updated with comments from the company's conference call to discuss the financial results. NEW YORK – Danaher reported a 3 percent year-over-year increase in third quarter revenues on Tuesday as growth for its Cepheid and Beckman Coulter Diagnostics businesses were offset by softness in China for its life sciences and diagnostics segments.